William R. Cantrell

453 total citations
11 papers, 366 citations indexed

About

William R. Cantrell is a scholar working on Organic Chemistry, Molecular Biology and Genetics. According to data from OpenAlex, William R. Cantrell has authored 11 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 5 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in William R. Cantrell's work include Cancer therapeutics and mechanisms (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). William R. Cantrell is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). William R. Cantrell collaborates with scholars based in United States, Japan and United Kingdom. William R. Cantrell's co-authors include Larry Arthaud, John A. Secrist, Peter L. Bonate, Katherine Stephenson, Steve Weitman, William E. Bauta, Bruce G. Anderson, John A. Gladysz, George B. Richter‐Addo and Bruce C. Anderson and has published in prestigious journals such as Nature Reviews Drug Discovery, Tetrahedron Letters and Journal of Organometallic Chemistry.

In The Last Decade

William R. Cantrell

11 papers receiving 354 citations

Peers

William R. Cantrell

ONCOL

HEMAT

Larry Arthaud United States

Finn Myhren Netherlands

Eun Jung Ko South Korea

Katherine Stephenson United States

Hywyn Churchill United States

Chang‐Soo Yun South Korea

F. Di Pisa Italy

Byung Ju Kim Canada

Patrycja Wińska Poland

A. Pískala Czechia

Larry Arthaud United States

William R. Cantrell

149 ×0.9

51 ×0.4

68 ×0.9

ONCOL

45 ×0.7

62 ×1.2

HEMAT

Citations per year, relative to William R. Cantrell William R. Cantrell (= 1×) peers Larry Arthaud

Countries citing papers authored by William R. Cantrell

Since Specialization

Citations

This map shows the geographic impact of William R. Cantrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Cantrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Cantrell more than expected).

Fields of papers citing papers by William R. Cantrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William R. Cantrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Cantrell. The network helps show where William R. Cantrell may publish in the future.

Co-authorship network of co-authors of William R. Cantrell

This figure shows the co-authorship network connecting the top 25 collaborators of William R. Cantrell. A scholar is included among the top collaborators of William R. Cantrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William R. Cantrell. William R. Cantrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

McHardy, Stanton F., Jonathan Bohmann, Michael Tidwell, et al.. (2014). Design, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase. Bioorganic & Medicinal Chemistry Letters. 24(7). 1711–1714. 21 indexed citations

Gianolio, Diego A., Cécile Rouleau, William E. Bauta, et al.. (2012). Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates. Cancer Chemotherapy and Pharmacology. 70(3). 439–449. 28 indexed citations

Anderson, Bruce G., William E. Bauta, & William R. Cantrell. (2012). Development of an Improved Process for Doxercalciferol via a Continuous Photochemical Reaction. Organic Process Research & Development. 16(5). 967–975. 29 indexed citations

Cantrell, William R., et al.. (2008). Synthetic Studies on Formamidopyrimidines Related to Clofarabine. Nucleosides Nucleotides & Nucleic Acids. 27(8). 901–913. 2 indexed citations

Anderson, Bruce G., et al.. (2008). Isolation, Synthesis, and Characterization of Impurities and Degradants from the Clofarabine Process. Organic Process Research & Development. 12(6). 1229–1237. 13 indexed citations

Bonate, Peter L., Larry Arthaud, William R. Cantrell, et al.. (2006). Discovery and development of clofarabine: a nucleoside analogue for treating cancer. Nature Reviews Drug Discovery. 5(10). 855–863. 211 indexed citations

Cantrell, William R., et al.. (2006). Hydrogen peroxide promoted hydroxylation of haloarenes and heteroarenes. Tetrahedron Letters. 47(25). 4249–4251. 12 indexed citations

Cantrell, William R., et al.. (2006). Preparation of a Fludarabine Intermediate via Selective Alkylation of 2-Fluoroadenine. Nucleosides Nucleotides & Nucleic Acids. 25(7). 735–745. 2 indexed citations

Bauta, William E., et al.. (2004). A New Process for Antineoplastic Agent Clofarabine. Organic Process Research & Development. 8(6). 889–896. 26 indexed citations

10.

Johnson, Erik P., et al.. (1998). Efficient Large Scale Preparation of Neutral Endopeptidase/Angiotensin-Converting Enzyme Dual Inhibitor CGS30440. Organic Process Research & Development. 2(4). 238–244. 3 indexed citations

11.

Cantrell, William R., George B. Richter‐Addo, & John A. Gladysz. (1994). Syntheses of cyclic imine complexes of the chiral rhenium Lewis acid [(ν5-C5H5) Re(NO)(PPh3)]+ by hydride ion abstraction from amido complexes. Journal of Organometallic Chemistry. 472(1-2). 195–204. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact